
GC11245
XMU-MP-1
Also known as 4-[(2,9-dimethyl-8-oxo-6-thia-2,9,12,14-tetrazatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-13-yl)amino]benzenesulfonamide
XMU-MP-1 is a reversible and selective inhibitor of MST1/2 kinase, with IC50s of 71·1±12·9 nM and 38·1±6·9 nM for MST1 and MST2 respectively
ChemicalCAS2061980-01-4MW416.48FormulaC17H16N6O3S2
- CAS number
- 2061980-01-4
- Molecular weight
- 416.48
- Formula
- C17H16N6O3S2
- Solubility
- ≥ 41·6mg/mL in DMSO with gentle warming
- InChIKey
- YRDHKIFCGOZTGD-UHFFFAOYSA-N
- Catalogue number
- GC11245
- Brand
- GLPBIO
Computed properties PubChem CID 121499143 · XLogP 1.8 · TPSA 158 Ų · H-bond donors 2
- XLogP
- 1.8
- TPSA
- 158 Ų
- H-bond donors
- 2
- H-bond acceptors
- 9
- Rotatable bonds
- 3
- Heavy atoms
- 28
SMILES CN1C2=C(C(=O)N(C3=CN=C(N=C31)NC4=CC=C(C=C4)S(=O)(=O)N)C)SC=C2
Computed descriptors from PubChem (CID 121499143), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il